Table 3

Logistic regression findings of factors affecting IF in patients with HIV infection, 2003–2015, Jimma, Ethiopia

VariableIF (n, %†)COR (95% CI)AOR (95% CI):
complete cases
AOR (95% CI):
multiple imputations
NoYes
Age (years)
 15 to ≤25488 (15.4)74 (9.5)111
 25 to ≤502560 (80.9)674 (87)1.7 (1.3 to 2.3)*1.5 (1.2 to 2.4)*1.8 (1.7 to 2.1)*
 50+116 (3.7)27 (3.5)1.5 (0.9 to 2.5)1.3 (0.7 to 2.9)2.3 (1.9 to 2.7)*
Sex
 Male1488 (47)274 (35.4)111
 Female1676 (53)501 (64.6)1.6 (1.4 to 1.9)*1.8 (1.3 to 1.9)*1.7 (1.6 to 1.8)*
Marital status
 Never married632 (23.3)152 (21.7)11
 Married1316 (48.5)357 (51.1)1.1 (0.9 to 1.4)1.04 (0.0 to 1.1)
 Separated/divorced/
 widowed
766 (28.2)190 (27.2)1.03 (0.8 to 1.3)1.9 (0.7 to 2.1)
Educational status
 No education559 (20.5)145 (20.8)111
 Primary1089 (39.9)287 (41.1)1.01 (0.8 to 1.3)1.3 (0.7 to 2.9)1.03 (0.9 to 1.1)
 Secondary and above1084 (39.7)266 (38.1)0.9 (0.8 to 1.2)0.7 (0.4 to 3.7)0.9 (0.8 to 1.1)
Religion
 Muslim871 (32)239 (34.5)11
 Christian‡1849 (68)453 (65.5)0.9 (0.8 to 1.06)0.8 (0.7 to 1.9)
Baseline WHO status
 Stage 1 or 2842 (45.1)216 (46.6)11
 Stage 3 or 41027 (54.9)248 (53.4)0.9 (0.8 to 1.2)1.7 (0.8 to 3.9)
Baseline CD4
 ≥200 cells/μL2558 (80.8)350 (45.2)111
 <200 cells/μL606 (19.2)425 (54.8)5.1 (4.3 to 6.06)*5.5 (4.1 to 7.4)*1.8 (0.9 to 3.01)
Clinical failure
 No1493 (81.3)352 (80.5)111
 Yes343 (18.7)85 (19.5)1.1 (0.8 to 1.4)1.3 (0.9 to 1.8)2.8 (0.7 to 4.9)
HIV care presentation
 Early682 (36.5)99 (21.3)111
 Late1187 (63.5)365 (78.7)2.1 (1.7 to 2.7)*2.2 (1.6 to 2.7)*1.1 (1.01 to 1.2)*
Hx of TB/HIV coinfection
 No2229 (70.4)536 (69.2)111
 Yes935 (29.6)239 (30.8)1.06 (0.9 to 1.3)1.8 (0.7 to 4.9)1.08 (1.01 to 1.2)*
ART adherence
 Good2595 (82)648 (83.6)11
 Fair or poor569 (18)127 (16.4)0.9 (0.7 to 1.1)0.9 (0.8 to 1.9)
Cotrimoxazole adherence
 Good2632 (83.5)639 (82.5)1
 Fair or poor521 (16.5)136 (17.5)0.9 (0.8 to 1.2)
Baseline functional status
 Working or ambulatory1992 (68.1)549 (74.7)11
 Bedridden933 (31.9)186 (25.3)0.7 (0.6 to 0.9)*0.8 (0.6 to 1.02)
Hx of HIV testing
 Yes1793 (56.7)468 (60.4)111
 No1371 (43.3)307 (39.6)0.9 (0.7 to 1.0)0.7 (0.5 to 0.9)*0.8 (0.7 to 0.9)*
ART shift
 No2086 (98.9)500 (99.2)11
 Yes24 (1.1)4 (0.8)0.7 (0.2 to 2.01)0.8 (0.6 to 1.03)
  • *Statistically significant at p≤0.05.

  • †Only valid percentage is considered.

  • ‡Orthodox, protestant or catholic.

  • AOR, adjusted OR; ART, antiretroviral therapy; CD4, cluster for differentiation 4; COR, crude OR; IF, immunological failure; TB, tuberculosis.